Page last updated: 2024-08-25

xanthomicrol and Liver Neoplasms

xanthomicrol has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bo, N; Chen, S; Fan, YC; Jiang, LH; Lin, ZZ; Wu, YT; Yao, HL; Yu, HF	1

Other Studies

1 other study(ies) available for xanthomicrol and Liver Neoplasms

Article	Year
Xanthomicrol suppresses human hepatocellular carcinoma cells migration and invasion ability via Μu-opioid receptor. The Journal of pharmacy and pharmacology, 2022, Jan-05, Volume: 74, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Epithelial-Mesenchymal Transition; Flavones; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Neoplasm Invasiveness; Receptors, Opioid, mu	2022

Article

Year

Xanthomicrol suppresses human hepatocellular carcinoma cells migration and invasion ability via Μu-opioid receptor.

The Journal of pharmacy and pharmacology, 2022, Jan-05, Volume: 74, Issue:1

Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Epithelial-Mesenchymal Transition; Flavones; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Neoplasm Invasiveness; Receptors, Opioid, mu

2022